海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
507件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- The repair of early tooth decay after drinking milk containing added casein
- Dental decay
- Australia
- 2007-12-20
Not recruiting
- Is Adding E2 to P4 Luteal Support In High Responder Long Gn-RH Agonist ICSI Cycles Detrimental to Outcome? RCT
- IVF;Infertility
- Egypt
- 2013-02-08
Authorised
- To evaluate the efficacy and safety of CNP520 in participants at risk for the onset of clinical symptoms of Alzheimer’s Disease (AD)
- Alzheimer's disease MedDRA version: 19.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Argentina, Austria, Belgium, Canada, Chile, China, Finland, France, Germany, Hong Kong, Iceland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Portugal, Singapore, South Africa, Spain, Taiwan, United Kingdom, United States
- 2017-03-31
Recruiting
- A 12 Week study to assess Safety & efficacy of QAW039 when added to standard of care in patients with uncontrolled asthma
- Moderate persistent asthma
- Argentina, Canada, Czech Republic, Greece, India, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Panama, Russian Federation, Serbia, Slovakia, South Africa, Spain, Taiwan, United States of America
- 2018-06-15
Not Recruiting
- SR-PAAS - Sitaxentan Efficacy and Safety Trial With a Randomized Prospective Assessment of Adding Sildenafil
- Pulmonary Arterial Hypertension
- Argentina, Bulgaria, Chile, China, Colombia, Costa Rica, Czech Republic, Dominican Republic, Guatemala, India, Malaysia, Mexico, Peru, Philippines, Romania, Russian Federation, Saudi Arabia, Serbia, Slovakia, South Africa, Thailand, Turkey, Ukraine, United States of America
- 2009-05-13
Not recruiting
- A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)
- Dementia, Alzheimer Type
- Australia, United Kingdom, United States
- 2016-03-21
Not recruiting
- Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone
- Mycobacterium Infections, Nontuberculous;Mycobacterium Infections, Nontuberculous;Mycobacterium Infections, Nontuberculous
- Australia, Austria, Canada, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Poland, Spain, Sweden, Taiwan, Thailand, United Kingdom, United States
- 2015-01-09
Not recruiting
- Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes
- Type 2 Diabetes Mellitus
- Argentina, Australia, Brazil, Canada, Chile, India, Mexico, Peru, Philippines, Russian Federation, Taiwan, Thailand, Ukraine, United States
- 2005-03-31
Not recruiting
- Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)
- Pulmonary Arterial Hypertension;Pulmonary Hypertension;Pulmonary Arterial Hypertension;Pulmonary Hypertension;Pulmonary Arterial Hypertension;Pulmonary Hypertension;Pulmonary Arterial Hypertension;Pulmonary Hypertension
- Argentina, Bulgaria, Chile, China, Colombia, Costa Rica, Czech Republic, Dominican Republic, Egypt, Guatemala, India, Jordan, Lebanon, Malaysia, Mexico, Peru, Philippines, Romania, Russian Federation, Saudi Arabia, Serbia, Slovakia, South Africa, Thailand, Turkey, Ukraine, United Arab Emirates, United States
- 2008-11-20
Not Recruiting
- Activity during television advertisement breaks to offset the adverse effects of prolonged sitting: The ‘Active Ads’ study
- impaired glucose tolerance ;obesity ;endothelial function ; insulin levels; impaired glucose tolerance obesity endothelial function insulin levels;Metabolic and Endocrine - Diabetes;Public Health - Health promotion/education
- Australia
- 2016-06-20